drugset / Trial / NCT00794625

Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)

NCT00794625 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will determine the advantages and disadvantages of adding one of two different types of drugs to stimulant treatment for reducing aggressive behavior in children with attention deficit with hyperactivity disorder (ADHD).

Timeline

Start
2008-11
Primary completion
2012-11
Completion
2013-04

Outcome

Met primary endpoint

paper The adjunctive RISP group showed greater reductions in aggression ratings than the PBO group PMID 32007604 ↗

paper as did the DVPX group PMID 32007604 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule — —
Subject Methylphenidate Small molecule — —
Subject Risperidone Other / unclassified — —
Subject Valproate Small molecule — —